Current Grants

Current Grants Awarded to Faculty

  • Shanjana Awasthi, Ph.D.

    Title of Project: "Surfactant protein-A regions as TLR4-immunomodulators"

    • Sponsoring Agency: National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)
    • Time Period: 08/08/17 through 07/31/22

  • Vibhudutta Awasthi, Ph.D.

    Title of Project: "Immunokinetics of superhydrophili polymer-modified liposome encapsulated hemoglobin"

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 09/01/17 through 08/31/20

    Title of Project: "Pharmacotherapy of traumatic brain injury accompanied by hemorrhagic shock.""

    • Sponsoring Agency: Department of Defense (DoD)
    • Time Period: 09/30/17 through 09/29/20

  • Randle Gallucci, Ph.D.

    Title of Project: "The role of specific inflammatory mediators in keratinocyte function and wound healing."

    • Sponsoring Agency: Presbyterian Health Foundation (seed grant)
    • Time Period: 07/01/18 - 06/30/19

  • Anne Kasus-Jacobi, Ph.D.

    Title of Project: "Wound healing mechanisms modulated by novel antimicrobial peptides."

    • Sponsoring Agency: NIH/National Eye Institute
    • Time Period: 09/30/16 - 08/31/19

  • Shellie Keast, Pharm.D., M.S., Ph.D.

    Title of Project: "Research Fellowship Agreement."

    • Sponsoring Agency: Purdue Pharma
    • Time Period: 08/01/16 - 12/31/18

    Title of Project: "Drug Utilization Review (DUR) board contract."

    • Sponsoring Agency: Oklahoma Health Care Authority
    • Time Period: 07/01/18 - 06/30/19

    Title of Project: "Alternate payment model pilot program."

    • Sponsoring Agency: NASH Policy
    • Time Period: 09/01/17 - 07/31/19

    Title of Project: "Development of a predictive model for METAVIR fibrosis scores for patients chronically infected with Hepatitis C Virus."

    • Sponsoring Agency: AbbVie
    • Time Period: 10/16/17 - 10/15/18

    Title of Project: "Medicaid Population Characterization project."

    • Sponsoring Agency: Amgen
    • Time Period: 08/16/18 - 08/15/19

    Title of Project: "Improving evidence-based antibiotic use for treatment of infections commonly seen in long term care."

    • Sponsoring Agency: Oklahoma State Dept. of Health
    • Time Period: 07/01/18 - 06/30/20

  • William M. McShan, Ph.D.

    Title of Project: "Phage-like chromosomal islands and virulence in pneumococci"

    • Sponsoring Agency: NIH Center of Biomedical Research Excellence (CoBRE)/Oklahoma State University (OSU); Oklahoma Center for Respiratory and Infectious Diseases (OCRID)
    • Time Period: 07/01/18 through 06/30/19

  • Motolani E. Ogunsanya, Ph.D.

    Title of Project: "Assessing the cutaneous lupus erythematosus quality of life (CLEQol) scale: Longitudinal change and clinical applicability."

    • Sponsoring Agency: Presbyterian Health Foundation (seed grant)
    • Time Period: 07/01/18 - 06/30/19

  • H. Anne Pereira, Ph.D.

    Title of Project: "51st annual meeting of the Society for Leukocyte Biology (SLB). Leukocyte memory: Health and disease."

    • Sponsoring Agency: National Institutes of Health/National Institute of Allergy and Infectious Diseases (NIAID)
    • Time Period: 06/20/18 through 05/31/19

  • R. Chris Rathbun, Pharm.D.

    • Title of Project: "HIV Drug Assistance Program (HDAP) to promote adherence."
    • Sponsoring Agency: Oklahoma State Department of Health
    • Time Period: 04/01/11 through 03/31/2019

  • Amanda Sharpe, Ph.D.

    Title of Project: "The role of dendrodendritic dopamine neurotransmission in methamphetamine abuse."

    • Sponsoring Agency: Oklahoma Medical Research Foundation
    • Time Period: 09/01/17 - 11/30/18

    Title of Project: "Effects of dietary restriction on age-related neurophysiological adaptations; from behavior to single dopaminergic neurons."

    • Sponsoring Agency: Oklahoma Medical Research Foundation
    • Time Period: 05/01/18 - 04/30/21

    Title of Project: "Effect of obesity on proopiomelanocortin regulation of reward and feeding."

    • Sponsoring Agency: Presbyterian Health Foundation
    • Time Period: 07/01/2018 - 05/30/2019

  • Kelly Standifer, Ph.D.

    Title of Project: "Post-traumatic stress disorder and co-morbid chronic pain: Evidence that TNF initiates a sequelae involving nocioceptin/orphanin FQ"

    • Sponsoring Agency: Oklahoma Center for the Advancement of Science and Technology (OCAST)
    • Time Period: 08/01/17 through 07/31/20

  • Sukyung Woo, Ph.D.

    Title of Project: "Overcoming resistance to Anti-VEGT therapy with predictive modeling."

    • Sponsoring Agency: American Cancer Society (ACS)
    • Time Period: 07/01/16 through 06/30/20

  • Youngjae You, Ph.D.

    Title of Project: "Visible light-controlled combination strategy for treating nonmuscle invasive bladder cancers"

    • Sponsoring Agency: Department of Defense (DoD)
    • Time Period: 08/01/17 through 07/31/19
    Title of Project: "NIR-activatable prodrugs for treating peritoneally metastasized ovarian cancers"
    • Sponsoring Agency: National Institutes of Health/National Institute of General Medical Sciences (NIH/NIGMS)
    • Time Period: 03/01/15 through 01/31/20

    Title of Project: "NIR-activatable prodrugs for treating peritoneally metastasized ovarian cancers." (Equipment).

    • Sponsoring Agency: National Institutes of Health/National Institute of General Medical Sciences 9NIH/NIGMS)
    • Time Period: 07/01/16 - 01/31/20

  • Wei Yue, Ph.D.

    Title of Project:"AFPE Pre-doctoral fellowship for Alex Crow"e - Year 2"

    • Sponsoring Agency: American Foundation for Pharmaceutical Education (AFPE)
    • Time Period: 09/01/18 through 08/31/19